The Harvard Drug Group, LLC, Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg, and Ziprasidone Hydrochloride Capsules, 20 mg, Because of Label Mix-Up
On June 14, 2023, the U.S. Food and Drug Administration reported that the Harvard Drug Group, LLC, conducting business as Major Pharmaceuticals and Rugby Laboratories, issued a voluntary recall of a single lot of dronabinol capsules, USP, 2.5 mg, and ziprasidone hydrochloride capsules, 20 mg, after receiving a report that some unit dose cartons labeled as ziprasidone hydrochloride capsules, 20 mg, contained blister packages labeled as and containing dronabinol capsules, USP, 2.5 mg.
Cancer Center Cultivates Novel Herbal Oncology Program
Nearly 60% of patients with cancer turn to herbal supplements for symptom relief, but patient-physician communication about that use remains inadequate. Unsupervised herbal use can lead to adverse events and herb-drug interactions for patients during active treatment. Many physicians and providers also lack sufficient knowledge about herbal supplements to help patients make informed decisions.
Most Cancer Screening Guidelines Don’t Disclose Potential Harms
For nearly 2,500 years, nonmaleficence, or “do no harm,” has been a fundamental tenet of medical ethics. Yet none of today’s U.S. breast, cervical, colorectal, lung, or prostate cancer screening guidelines report all of the harms associated with screening tests, researchers said in study results published in Annals of Internal Medicine.
CMS Promotes Plans to Build a System for Patient Safety
Across disciplines, all healthcare providers take a practice oath that supports the principle of nonmaleficence (“first, do no harm”)—and so does the Centers for Medicare and Medicaid Services (CMS), several agency leaders wrote in a March 2023 blog post. The authors called for increased awareness of patient safety and highlighted ways CMS is taking action.
FDA Recommends Stopping Use of Certain Owens and Minor Halyard Surgical N95 Respirators, Surgical Masks, and Pediatric Face Masks Because of Risk of Protection Failure
On April 12, 2023, the U.S. Food and Drug Administration issued a safety communication to healthcare providers, institutions, and consumers recommending that they do not use certain surgical N95 respirators manufactured by Owens and Minor Halyard and that they use certain surgical masks and pediatric face masks from Owens and Minor Halyard with caution. The recommendation comes after the masks failed fluid resistance performance tests.
Spectrum Laboratory Products, Inc., Issues Voluntary Recall of Epinephrine USP, Bulk API, Because of Product Discoloration
On January 9, 2022, the U.S. Food and Drug Administration reported that Spectrum Laboratory Products, Inc., issued a voluntarily recall of three lots of epinephrine (l-adrenaline), USP, used to manufacture or compound prescription products, at the user level because of customer reports that the product is discolored.
Latest CDC Clinical Practice Guideline Facilitates Safe Use of Opioids for Pain
Giving providers the latest evidence to inform the safe use and management of opioid prescriptions for cancer-related and other types of short- and long-term pain, the Centers for Disease Control and Prevention updated and expanded its recommendations in November 2022. The updated information was published in the CDC Clinical Practice Guideline for Prescribing Opioids for Pain, which replaces the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.
Exela Pharma Sciences, LLC, Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection Because of Vial Breakage
On October 13, 2022, the U.S. Food and Drug Administration reported Exela Pharma Sciences, LLC’s, voluntary recall of 49 lots of sodium bicarbonate injection, USP, 8.4%, 50 mEq/50 ml vial, 20-count carton, to the consumer level because of potential vial breakage and flying glass when pressurized while preparing for administration.
National COVID-19 Preparedness Plan Creates Path Out of Pandemic
President Joe Biden released the National COVID-19 Preparedness Plan in March 2022, enabling the United States to move forward with goals to protect against and treat COVID-19, prepare for new variants, prevent economic and educational shutdowns, and expand vaccinations.
Legislators, Professional Organizations Advocate for Safety Protections for Healthcare Workers
Shortly after emergency workplace safety standards were removed and guidance on isolation time following a positive COVID-19 test result was updated, healthcare workers and administrations urged legislators to issue protections for the profession. To ensure their voices were heard, House of Representatives legislators Robert C. “Bobby” Scott (D-VA) and Alma Adams (D-NC) wrote a letter to President Joe Biden and Department of Labor Secretary Marty Walsh to advocate for a reversal.
Study Ranks U.S. Healthcare Industry Dead Last Among Other High-Income Countries
The United States is worst among 11 high-income countries in delivery of and access to health care, according to an August 2021 study conducted by the Commonwealth Fund, despite spending the most, by far, of its gross domestic product (GDP) on health care than other countries surveyed. The survey used indicators across domains on access to care, care process, administrative efficiency, equity, and healthcare outcomes to compare healthcare system performance. Overall, the top-performing countries were Norway, the Netherlands, and Australia.
OSHA Issues Emergency Temporary Standard to Protect Healthcare Workers From COVID-19
“Frontline healthcare workers have a nearly 12-times higher risk of testing positive for COVID-19 compared with individuals in the general community,” according to the results of a 2020 study. Although U.S. vaccination rates continue to increase and infection rates continue to decrease, national government entities such as the U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) are releasing new guidelines to help protect those who are putting themselves at risk for transmission so they can care for others.
Senate Bill Addresses PPE Shortage
As the country sees dramatic spikes in COVID-19 coronavirus cases in fall 2020, political leaders are seeking to find solutions to deliver personal protective equipment (PPE) to healthcare workers on the front lines. U.S. Senator Tammy Baldwin (D-WI) introduced the Protect Our Heroes Act of 2020 to increase the production of PPE and spur oversight into the supply and distribution of these necessary medical supplies.
Nurses Account for Largest Group of Healthcare Providers With COVID-19 Infections
Nurses on the front lines of the COVID-19 coronavirus pandemic are at greater risk of infection than other clinicians, according to the COVID-19 Associated Hospitalization Surveillance Network, a Centers for Disease Control and Prevention report. Nurse-related occupations, including nurses and certified nursing assistants, represent the largest proportion (36%) of healthcare providers hospitalized with COVID-19. The national survey brought to light what many nurses may have already known: nursing as a profession bears the brunt of the pandemic.
Healthcare Worker Shortage; Trump Clashes With Big Pharma; Surprise Billing
Houston, TX, Miami, FL, and Baton Rouge, LA, are three of the many cities battling repercussions from the COVID-19 coronavirus pandemic. Most daunting is the perpetuated shortage of healthcare workers as the pandemic continues to ravage the United States.
What’s Working and What Isn’t in Telemedicine
Half of all healthcare professionals have started using telemedicine in response to the COVID-19 coronavirus pandemic. Patients and providers are trying to adjust to such rapid changes in the provision of health care. Providers want to know how to get reimbursement for telemedicine visits. Society is working together to answer the critical questions about this next wave of health care.
Nurse-Turned-Policymaker; Prescription Drug Reform; Safer Working Conditions
As one of the youngest members of the 2018 freshman congressional class, U.S. Representative Lauren Underwood (D-IL) has already made quite a name for herself. Eschewing, for the most part in this heightened environment, partisanship and instead concentrating on health and economic issues, the representative champions access and affordability for all Americans.
Telehealth Boom Opens New Roles for Oncology Nursing
Seemingly overnight, many patients went from viewing telehealth as an intimidating frontier to embracing it with gusto. Fortunately, health care has prepared for years to put the infrastructure and people in place to support telehealth expansion.
How COVID-19 Is Affecting Oncology Practice in South Korea
Oncology nurses around the world are seeing the effects of the COVID-19 coronavirus pandemic in their practices. At my facility in South Korea, nurses’ daily routines have changed and institution-wide shifts have affected patients with cancer, too.
U.S. Surgeon General on COVID-19: 'It's Going to Get Bad'
Deployed to provide expert medical advice about the COVID-19 coronavirus pandemic, U.S. Surgeon General Jerome Adams, MD, made media rounds the first week of April 2020. Although the news he shared wasn’t positive, it was a necessary message that the United States needed to hear.
Healthcare Industry Looks to Public Amid COVID-19 PPE Supply Shortage
Nurses and other healthcare providers on the front lines of the COVID-19 coronavirus pandemic are facing a shortage of personal protective equipment (PPE), including gloves, face shields, and N95 face masks. But grassroots efforts from citizens and companies are bringing PPE donations or funneling supplies from donors to medical facilities in response to pleas from the healthcare community.
Take Patients From Falls Risk to Mobility
Promoting a culture of safety is the responsibility of all members of the healthcare team. Nurses and advanced practice providers have a unique role in ensuring patient safety, especially through interventions aimed at reducing the risk of falls and falls with injury. Hundreds of thousands of hospitalized patients fall each year, each costing organizations an average additional $14,000 and resulting in more than six additional hospital days. Up to 30% of falls result in injury, including fractures, decreased mobility, and a loss of independence.
USP <800> Implementation Delayed to December 2019
The U.S. Pharmacopeia (USP) announced on September 29, 2017, it would delay the implementation of USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings to coordinate its implementation with chapter <797> Pharmaceutical Compounding—Sterile Preparations. According to USP, chapter <797> is still undergoing revisions and will be available for public comment in fall 2018. UPS <800> was set for implementation by July 1, 2018, but both chapters are now expected to become official on December 1, 2019.
ONS Connects You to Cutting-Edge Standards to Support Your Practice
Healthcare Associated Infection (HAI) Prevention Resources
Healthcare Associated Infections (HAIs) can derail your cancer patients' treatment plan. Learn more about HAIs and access resources to help reduce this risk. Tools from CDC and Prevent Cancer Infections.org are available HERE, courtesy of BD.